IP Library Granted Patent US 8,071,533
Granted Patent B2
US 8,071,533 · App. 12/279,871 · Granted Dec 6, 2011

Compositions and methods for modulating store-operated calcium entry

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,071,533
App. No.
12/279,871
Granted
Dec 6, 2011
Kind
B2
Abstract

Compositions and methods for modulating activity of store-operated calcium entry in cells or tissues are provided. The compositions comprise the P311 protein, fused to a cell-penetrating peptide and formulated for delivery to tissues and cells. This protein has been shown to increase the levels of store-operated calcium entry (SOCE) in gingival cells, skeletal muscle cells, and prostate epithelial cells. Also provided are methods for preventing and treating diseases that involve administration of the P311 fusion protein, as well as methods for increasing levels of SOCE in cells.

Claims (19)

1. A composition for increasing store-operated calcium entry in a cell comprising

(a) an isolated and purified P311 protein fused to a cell penetrating peptide, and

(b) a pharmaceutically acceptable vehicle,

wherein said composition is formulated as toothpaste, a dental rinse, or a food supplement.

2. A method for increasing store-operated calcium entry in a cell comprising contacting a cell with a composition comprising

(a) an isolated and purified P311 protein fused to a cell penetrating peptide, and

(b) a pharmaceutically acceptable vehicle,

wherein contact of said cell with said composition results in an increase in the level of store-operated calcium entry in the cell.

3. The method of claim 2 , wherein said cell is a mammalian gingival cell, a skeletal muscle cell, or a prostate epithelial cell.

4. A method for preventing or treating dental disease in an animal comprising administering to an animal a therapeutically effective amount of a composition comprising

(a) an isolated and purified P311 protein fused to a cell penetrating peptide, and

(b) a pharmaceutically acceptable vehicle,

wherein administration of said composition to said animal results in prevention or treatment of dental disease.

5. The method of claim 4 , wherein said dental disease is gingivitis.

6. The method of claim 4 , wherein said composition is formulated as toothpaste, a dental rinse, or a food supplement.

7. A method for treating prostate cancer in an animal comprising administering to an animal with prostate cancer a therapeutically effective amount of a composition comprising

(a) an isolated and purified P311 protein fused to a cell penetrating peptide, and

(b) a pharmaceutically acceptable vehicle,

wherein administration of said composition to said animal results in treatment of prostate cancer.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2013
From: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 031700/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2009
From: MA, JIANJIE; WEISLEDER, NOAH; PAN, ZUI
To: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
Reel/Frame 022239/0388 →